Our free mini version of the classic crossword puzzle with a business twist. Perfect for the crossword enthusiast who only has a few minutes between meetings. New puzzles go live five days a week, ...

I’m the Editorial Director at BuzzFeed — where I’ve reported on TV, film, and lifestyle trends (travel, fitness, and food) since 2013 — and I also post about the latest in pop culture news to my 850k+ ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

If you click on links we provide, we may receive compensation. “If it doesn’t work across your wardrobe, it stays home.” Jeaneen Russell is a shopping writer for PEOPLE with over five years of ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

Nuclear magnetic resonance (NMR) spectroscopy stands as the most informative and widely used technique for molecular structure elucidation in organic chemistry 1. Unlike mass spectrometry or infrared ...

The latest trends in software development from the Computer Weekly Application Developer Network. Pathway is a post-transformer AI lab that claims to be delivering a faster path to AGI through true ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

I wrote an article last year exploring an extension of the eight queens problem, where instead of solving for an 8x8 board I did so for a 15x15 to show the power of backtracking algorithms as opposed ...

The consensus mark for RXRX's Q4 loss and sales are pinned at 28 cents per share and $25.5M, respectively. In late 2025, RXRX highlighted REC-4881 data showing rapid, durable polyp reductions in FAP ...